Results 191 to 200 of about 30,077 (242)

Progressive scleroderma in a patient with recent nasopharyngeal carcinoma [PDF]

, 2000
U. Srinivasan, Tom Lawson, Rhian Goodfellow, Bryan Williams   +3 more
openalex   +1 more source

Beyond fluorodeoxyglucose: Molecular imaging of cancer in precision medicine

CA: A Cancer Journal for Clinicians, EarlyView.
Abstract Cancer molecular imaging is the noninvasive visualization of a process unique to or altered in neoplasia, such as proliferation, glucose metabolism, and receptor expression, which is relevant to patient management. Several molecular imaging modalities are now available, including magnetic resonance, optical, and nuclear imaging.
Malik E. Juweid, Soud F. Al‐Qasem, Fadlo R. Khuri, Andrea Gallamini, Philipp Lohmann, Hans‐Joachim Ziellenbach, Felix M. Mottaghy   +6 more
wiley   +1 more source

Long‐term use of low‐dose aspirin for cancer prevention: A 20‐year longitudinal cohort study of 1,506,525 Hong Kong residents

International Journal of Cancer, Volume 156, Issue 12, Page 2330-2339, 15 June 2025.
What's New? Low‐dose aspirin use over an extended period is associated with a reduced risk of colorectal cancer (CRC) and potentially other malignancies. Duration of use to derive such benefits, however, remains unclear. This retrospective study examined low‐dose aspirin use for possible chemoprotective effects among individuals in Hong Kong.
Amy Lam, Ziyu Hao, Karen Yiu, Stephen Chan, Francis Chan, Joseph Sung, Kelvin Tsoi   +6 more
wiley   +1 more source

Efficacy and safety of JMT103 in patients with bone metastases from solid tumors: A randomized Phase Ib clinical trial

International Journal of Cancer, Volume 156, Issue 11, Page 2178-2187, 1 June 2025.
What's new? Bone metastases are common in a variety of cancer types, causing increased pain and worse outcomes. Suppression of bone turnover, such as with the monoclonal antibody denosumab, results in fewer skeletal complications and improved prognosis. Here, the authors demonstrate the safety and efficacy of a similar antibody, JMT103. Like denosumab,
Ran Ran, Hongtao Li, Tao Sun, Huan Zhou, Aimin Zang, Hongqian Guo, Hua Xie, Shikai Wu, Yong Yan, Xing Yin, Hailin Xiong, Hong Li, Jing Yuan, Juan Wang, Huiping Li, Jin Li   +15 more
wiley   +1 more source

Platelets: Novel Biomaterials for Cancer Diagnosis and Therapeutic Delivery

MedComm – Biomaterials and Applications, Volume 4, Issue 2, June 2025.
Platelets, particularly tumor‐educated platelets (TEPs), play a crucial role in cancer diagnosis and treatment. TEPs undergo molecular changes in RNA and protein profiles, making them valuable biomarkers for diagnosis, prognosis, and monitoring. In nanomedicine, platelets serve as drug carriers in tumor‐targeted nanomaterials, enhancing specificity and
Xin Wang, Jie Chen, Hubing Shi
wiley   +1 more source

102 Randomized multicentric international phase III trial of neoadjuvant chemotherapy (NACT) with bleomycin (B), epirubicin (E), cisplatin (C) followed by radiotherapy versus radiotherapy alone in undifferentiated carcinoma of nasopharyngeal type (UCNT) : Preliminary results

, 1995
F. Eschwège, B. El Gueddari, Ryszard Wierzbicki, U. Prassad, Zdenko Krajina, M. Altvn, N. Chryssanthou, Esteban Cvitkovic, E Benhamou   +8 more
openalex   +1 more source

Long‐term risk and characteristics of cerebrovascular events after upper body radiotherapy among childhood cancer survivors in the DCCSS‐LATER cohort

International Journal of Cancer, Volume 156, Issue 10, Page 1858-1872, 15 May 2025.
What's new? Due to the nature of cancer treatments, childhood cancer survivors have an increased risk of serious adverse events later in life. Here, the authors examined the incidence of cerebrovascular events (CVEs) among childhood cancer survivors who had received upper body radiotherapy.
Lisanne C. Verbruggen, Judith L. Kok, Leontien C. M. Kremer, Geert O. Janssens, Paul J. Nederkoorn, Adriaan Penson, A. Birgitta Versluijs, Andrica C. H. de Vries, Ardine M. J. Reedijk, Dorine Bresters, Eelco W. Hoving, Eline van Dulmen‐den Broeder, Jacqueline J. Loonen, Judith de Bont, Joyce Wilbers, Marloes Louwerens, Margriet van der Heiden‐van der Loo, Marry M. van den Heuvel‐Eibrink, Saskia M. F. Pluijm, Sebastian J. C. M. M. Neggers, Wim J. E. Tissing, Yvo B. W. E. M. Roos, Cécile M. Ronckers, Jop C. Teepen, Helena J. H. van der Pal, on behalf of the DCCSS‐LATER consortium, Jaap den Hartogh, Floor van Leeuwen, Irma van Dijk   +28 more
wiley   +1 more source

107 Radiosurgery for skull base malignancies and nasopharyngeal carcinoma

, 1995
Anthony J. Cmelak, M.D. Richard, S. Cox, John R. Adler, Willard E. Fee, Don R. Goffinet   +5 more
openalex   +1 more source

A comprehensive analysis of the tubarial glands

The Anatomical Record, Volume 308, Issue 5, Page 1425-1437, May 2025.
Abstract The tubarial glands (TGs) are a collection of salivary glands (SGs) located within the nasopharynx, proximal to the eustachian tube. Currently, there is no quantitative characterization of the TGs. We investigated the histological architecture of the TGs and compared it with the major and minor SGs for categorization.
Alisha Ebrahim, Caitlan Reich, Kurt Wilde, Aly Muhammad Salim, Martin D. Hyrcza, Lian Willetts   +5 more
wiley   +1 more source

1048 Parotid gland sparing using inverse planning for radiotherapy of nasopharyngeal carcinomas

, 1997
Kenneth Forster, John M. Sheldon, L.B. Harrison, H.J. Lee, R. Woode, C Burman, Chen‐Shou Chui, Margie Hunt, W. Lutz, Spiridon V. Spirou, G.J. Kutcher, Zvi Fuks, Steven A. Leibel, Cao Ling   +13 more
openalex   +1 more source